Tajikistan

You are here:-Tajikistan
Tajikistan2018-11-11T12:24:18+00:00

Background

TB remains a high priority public health threat throughout the Central Asia Region, with TB case detection and treatment success rates continuing to lag behind international targets and alarming increases in rates of MDR-TB. High rates of migration have the potential to further increase the spread of TB, especially MDR-TB, throughout the region.  Tajikistan has a TB incidence rate of 91 per 100,000.  The Government of Tajikistan (GOTJ) is currently undertaking efforts to integrate TB services into the primary health care (PHC) system and move away from overuse of hospitalization during treatment.

Infection Control Demonstration Site

In April 2014, TB CARE II, in partnership with the Tajikistan Ministry of Health and Social Protection, established the Macheton National TB Hospital in Tajikistan as an infection control demonstration site.  The purpose of this site is to document the magnitude of TB burden caused by poor infection control, establish more effective infection control practices, and to use the site as a training base to build national and regional interest and investment in TB infection control. Click here or more information.

Click here to read this topic in the STOP TB Partnership newsletter.